Brain atrophy observed in Alzheimer’s disease may be prevented by Ozempic’s drug semaglutide
ZEPHYR/Science Photo Library/Alamy
Ozempic and Wegovy are already transforming treatments for type 2 diabetes and obesity, and next year could add another disease that affects millions of people around the world to the list: Alzheimer’s disease There is.
Two clinical trials investigating Ozempic and Wegovy’s drug semaglutide as a treatment for early Alzheimer’s disease are scheduled to conclude in 2025. If the results are positive, this could lead to breakthroughs in the treatment of this intractable disease.
Source: www.newscientist.com
